PTAB’s Denial of IPR Petition Forecloses Defendant’s Inequitable Conduct Claim in District Court

May 15, 2020

Reading Time : 2 min

The defendant filed the IPR petition during the course of the infringement litigation. The defendant’s petition relied on the same prior art references that underpinned its proposed inequitable conduct claim. However, while the defendant’s motion to amend to add that claim was pending in the district court, the PTAB denied institution of the IPR. In doing so, the PTAB “expressly considered the . . . prior art references (which are the subject of [the defendant]’s inequitable conduct claim[]) and found that [the defendant] could not demonstrate a reasonable likelihood that such references would have rendered any claim of the [asserted] patent unpatentable.” Order at 6.

The district court subsequently denied the defendant’s motion to amend. The court first explained that leave to amend under Rule 15(a) “should be denied . . . [when] the amendment would be futile,” and that an “amendment is futile where [it] fails to state a claim as required by Rule 12(b)(6).” Id. at 2. The court then explained that, despite its general obligation under Rule 12(b)(6) to “accept all factual allegations in [a] pleading as true, [it] need not accept factual allegations ‘that contradict matters properly subject to judicial notice,’” such as the PTAB’s decision. Id. at 6 (quoting Veney v. Wyche, 293 F.3d 726, 730 (4th Cir. 2002)).

The court next examined the impact of the PTAB’s decision on the defendant’s proposed inequitable conduct claim. The court observed that “[t]o plead an inequitable conduct claim, [the defendant] must sufficiently plead materiality—that ‘but for’ the [undisclosed] prior art, the [Patent and Trademark Office] would not have allowed a claim in the [asserted] patent.” Id. In turn, the court stressed that, regardless of the defendant’s allegations of materiality in the proposed amendment, “the Court knows that the PTAB considered the [defendant’s relied-upon] prior art and did not find it material to patentability.” Id. (emphasis in original).

The court thus concluded that, “[i]n light of the PTAB’s decision denying IPR,” and even “assuming all [of the defendant’s] other factual allegations as true,” the proposed amendment did “not plausibly give rise to an entitlement to relief because [the defendant] cannot show that ‘but for’ the [relied-upon] prior art, the PTO would not have issued [] the [asserted] patent.” Id. at 7. In reaching its holding, the court rejected the defendant’s argument that it “should completely refrain from examining the merits of [the] inequitable conduct counterclaim and affirmative defense and only examine whether [the defendant] has sufficiently pleaded inequitable conduct.” Id. at 8. As the court observed, “this argument ignores the [] requirement to consider whether any amendment is futile . . . , and accordingly whether any amendment would withstand a motion to dismiss.” Id.

Practice Tip: The Jaguar decision exemplifies that a PTAB’s refusal to institute an IPR, even if not binding on a district court, can still have significant ramifications in infringement litigation involving the same patent. Although filing an IPR petition is a common tactic for alleged infringers, they should recognize that a negative ruling from the PTAB might effectively foreclose an inequitable conduct claim in district court. Similarly, a plaintiff facing an inequitable conduct claim based on failure to disclose prior art should consider whether the PTAB previously assessed the patentability of the asserted claims in light of that prior art.

Jaguar Land Rover Ltd. v. Bentley Motors Limited, No. 2:18-cv-320 (E.D. Va. Apr. 30, 2020)

Share This Insight

Previous Entries

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

IP Newsflash

September 9, 2025

The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.

...

Read More

IP Newsflash

August 29, 2025

In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue. 

...

Read More

IP Newsflash

August 29, 2025

The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.